Buy High Purity 1-Aminobenzotriazole (CAS 1614-12-6) from Reliable Manufacturer and Supplier in China

Discover 1-Aminobenzotriazole, a crucial pharmaceutical intermediate and potent CYP enzyme inhibitor. We are a leading manufacturer and supplier in China, offering high-quality products with competitive pricing for your research and production needs. Inquire now for a quote and sample.

Get a Quote & Sample

Key Advantages of Sourcing 1-Aminobenzotriazole from Us

Assured Quality and Purity

Our 1-Aminobenzotriazole meets stringent quality standards, with a minimum purity of 99.5%, making it suitable for critical pharmaceutical intermediate applications. We ensure consistency batch after batch, which is vital for reliable research outcomes.

Global Supply Chain Integration

As a leading China-based manufacturer and supplier, we offer a robust and stable supply of 1-Aminobenzotriazole, mitigating risks for your procurement strategy. We provide efficient logistics and timely delivery to global clients.

Expert Technical Support and Documentation

Access comprehensive technical documentation, including TDS, MSDS, and COA, to verify product specifications. Our team is ready to answer your questions and support your purchase decision for 1-Aminobenzotriazole.

Versatile Applications of 1-Aminobenzotriazole

Pharmaceutical Synthesis

Utilize 1-Aminobenzotriazole as a key intermediate in the synthesis of active pharmaceutical ingredients (APIs), ensuring the efficacy and quality of your drug products.

Drug Metabolism Research

Leverage its potent cytochrome P450 inhibitory properties to conduct in-depth studies on drug metabolism, pharmacokinetics, and toxicology, crucial for drug development.

Organic Synthesis

Employ 1-Aminobenzotriazole in complex organic synthesis projects requiring specialized reagents for creating novel chemical entities.

Biochemical and Toxicological Studies

Its role as a suicide substrate for CYP enzymes makes it invaluable for biochemical research, understanding enzyme kinetics and potential drug interactions.